Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
Understanding Commission Implementing Regulation (EU) 2025/1466 and Pharmacovigilance in 2026 and Beyond Commission Implementing Regulation (EU) 2025/1466, adopted on 22 July 2025 and implemented on 12 February 2026, marks one of the most significant updates to EU pharmacovigilance (PV) practice since the introduction of Implementing Regulation (EU...
PHUSE APAC Connect 2026 brought together clinical data leaders, programmers and statisticians from across the region, and Navitas Life Sciences was proud to be part of the conversation. (from left to right) – Sheikh Ibrahim, Pradip Sivaramakrishnan, Swapnil Udasi, Neeraj Malhotra, Anbarasan Durairajan , RamMohan Konda, Rahul Somavanshi. --> W...
What Is Data Management in Clinical Trials? Data management in clinical trials is the structured process of collecting, validating, cleaning, standardizing and preparing clinical trial data for statistical analysis and regulatory submission. How does data management work in clinical trials? In simple terms, clinical data management ensures that tri...
The biopharmaceutical industry is approaching a defining moment. Scientific breakthroughs across cell and gene therapies, precision oncology and novel biologics are accelerating faster than the systems designed to test them. This perspective is informed by recent industry thought leadership, including insights published by McKinsey & Company on...
In an industry defined by scientific complexity, global regulatory shifts and rising expectations for speed and quality, pharma and biotech organizations increasingly rely on life sciences consulting services that offer both strategic foresight and operational depth. Navitas Life Sciences stands apart as a pharma and biotech advisory partner with t...
How AI in Clinical Trials, Decentralized Clinical Trials and Real-World Evidence (RWE) Are Redefining Research Clinical research is entering 2026 with rising complexity and rising expectations. Sponsors are under pressure to accelerate development timelines, manage global operations, meet evolving regulatory requirements and deliver patient-centric...
A Year of Impact 2025 was a year of progress and partnership, where sponsors looked for the best CRO partner for global clinical trials, demanded inspection-ready clinical trial support for EMA inspections and needed teams that could deliver under pressure without compromising quality. Navitas Life Sciences worked alongside partners across clinical...
The Navitas Advantage: Powering the Future of Pharma & Biotech In today’s fast-moving world of pharma and biotech, innovation isn’t just an advantage—it’s a necessity. Scientific breakthroughs, evolving global regulations, and the relentless demand for speed and quality are rewriting the rules of drug development. To...
In a world where scientific innovation is accelerating fast, regulatory strategy is a competitive advantage. Pharma & biotech companies need clarity and deep multidisciplinary insight into the regulatory environment and the paths that competitors are taking to bring safe, effective products to market quickly. Whether developing a first-in-class...
Are you ready to lead the next wave of transformation in life sciences? Across Navitas’ industry-leading networks, pvnet®, pvconnect®, labelnet™, and more, over 100+ member companies are rewriting the playbook for 2026. Here’s what’s setting the pace for the industry’s boldest innovators: 1. Technology &...